Technetium-99m-Sestamibi Uptake in Myeloma

A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertak...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of nuclear medicine (1978) 1996-06, Vol.37 (6), p.1001-1002
Hauptverfasser:	Adams, Bruce K, Fataar, Abdulbasier, Nizami, Mohammad A
Format:	Artikel
Sprache:	eng
Schlagworte:	Female Humans Hyperplasia Immunoglobulin kappa-Chains - metabolism Middle Aged Multiple Myeloma - diagnostic imaging Multiple Myeloma - immunology Parathyroid Glands - diagnostic imaging Parathyroid Glands - pathology Radionuclide Imaging Technetium Tc 99m Sestamibi
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertaken for an unrelated hyperparathyroidism.
ISSN:	0161-5505 1535-5667